CoSyne Therapeutics logo

CoSyne Therapeutics

Precision medicine through polymathic AI

25 employees · est. 2021 · London, United Kingdom

VS
Skyhawk Therapeutics logo

Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing

81 employees · est. 2016 · Waltham, United States

Skyhawk Therapeutics is the older company (2021 vs 2016); Skyhawk Therapeutics is the larger of the two.

Side-by-Side Comparison

CoSyne Therapeutics Skyhawk Therapeutics
Founded
2021 2016 older
Headquarters
London, United Kingdom Waltham, United States
Employees
25 81 larger
Industry
Biotechnology Biotechnology, Health and Wellness
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $181.20M
Funding Rounds
Not tracked yet 6
Services
Not tracked yet Development of RNA-targeting small molecules, Conducting clinical trials, Collaborative drug development with pharma companies, Expanding internal pipeline for neurology, oncology, and fibrotic diseases
Target Customers
Not tracked yet Patients with Huntington's Disease, Pharmaceutical Companies, Biotechnology Researchers
Taxonomy
Precision Medicine, AI Drug Discovery, Polymathic AI, Under-served Diseases, Brain Diseases, Synthetic Lethality, Novel Therapeutic Opportunities, Genomics, Chemistry AI, Drug Development, Healthcare Innovation, Medical Research, Job Opportunities Small Molecule Therapeutics, RNA Splicing Modification, Drug Discovery, RNA-based Disease Treatment, Cancer Therapeutics, Neurological Condition Treatments, Proprietary Technology, Therapeutics Development, Exon Skipping, RNA Expression Correction, Binding Pocket Targeting, Sequence Specificity, Structural Specificity, Waltham-based
Website
cosyne.com skyhawktx.com
CoSyne Therapeutics logo

About CoSyne Therapeutics

CoSyne Therapeutics is a biotechnology startup based in the United Kingdom, founded in 2021 with a mission to advance precision medicine through the application of polymathic AI. The company's slogan, "Precision medicine through polymathic AI," reflects its core focus on leveraging AI for drug disco...

Skyhawk Therapeutics logo

About Skyhawk Therapeutics

Skyhawk Therapeutics, founded in 2016, is at the forefront of drug discovery and development within the Biotechnology and Health and Wellness industries. Stationed in Waltham, Massachusetts, this innovative company is pioneering the treatment of diseases with small molecules designed to modify RNA s...

We will tell you when either one moves

BounceWatch watches CoSyne Therapeutics and Skyhawk Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CoSyne Therapeutics and Skyhawk Therapeutics — by email.

Frequently Asked Questions

CoSyne Therapeutics — Precision medicine through polymathic AI . Skyhawk Therapeutics — We Use Small Molecules To Modify RNA Splicing. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CoSyne Therapeutics has raised undisclosed funding while Skyhawk Therapeutics has raised $181.20M.
CoSyne Therapeutics and Skyhawk Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CoSyne Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CoSyne Therapeutics on 14 Sep 2024, and Skyhawk Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes